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ABSTRACT 43 
Deficiency of selenium (Se), an essential micronutrient, has been implicated in adverse pregnancy 44 
outcomes. Our study was designed to determine total serum Se, selenoproteins [extracellular 45 
glutathione peroxidase (GPx-3), selenoprotein P (SeP)], selenoalbumin (SeAlb) and 46 
selenometabolites (SeMetab) in healthy women and their newborns at delivery. A cross-sectional 47 
study included 83 healthy mother-baby couples. Total Se and Se-species concentrations were 48 
measured in maternal and umbilical-cord serum by an in-series coupling of two-dimensional size-49 
exclusion and affinity high-performance liquid chromatography (2D/SE-AF-HPLC). Additional 50 
measurements were made of serum SeP concentration by ELISA and of serum GPx-3 enzyme 51 
activity. Total Se concentration was significantly higher in maternal serum than in cord serum 52 
(68.9±15.2 and 56.1±14.6 µg/L respectively; p<0.01). There were significant correlations between 53 
selenoprotein and SeAlb concentrations in mothers and newborns, although they also showed 54 
significant differences: GPx-3 (11.2±3.7 vs 10.5±3.5 µg/L; p<0.01) SeP (42.5±9.5 vs 28.1±7.7 µg/L; 55 
p<0.01) and SeAlb (11.6±3.6 vs 14.1±4.3 µg/L; p<0.01) in maternal and cord serum, respectively. 56 
Serum GPx-3 activity and concentration were correlated positively in mothers (r=0.33; p=0.038) but 57 
not in newborns. GPx-3 activity in cord serum was significantly correlated with gestational age 58 
(r=0.44; p=0.009). SeAlb concentration was significantly higher in babies while SeP and GPx-3 were 59 
significantly higher in mothers. The differences cannot be explained by simple diffusion; specific 60 
transfer mechanisms are probably involved. GPx-3 concentrations in mothers at delivery are related 61 
to maternal Se status, while the GPx-3 activity in cord serum depends on gestational age.  62 
 63 
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INTRODUCTION 76 
Selenium (Se) is an essential micronutrient with a wide range of protective functions, which are 77 
exerted through its incorporation into selenoproteins (1). Inadequate dietary Se intake can compromise 78 
human reproduction since Se deficiency has been associated with obstetric and perinatal 79 
complications such as male and female infertility, miscarriage, pre-eclampsia, intrauterine growth 80 
restriction, preterm delivery and neural defects in the offspring (2-4). 81 
The maternal-fetal transfer mechanisms for Se and selenoproteins have been studied in mice (5) and 82 
in placental models in vitro 6, leading to the identification of some specific placental transporters (6,7). 83 
Though a number of studies have measured Se concentrations in mothers and newborns at the time 84 
of birth, they have had contradictory results (8-10). To some extent, these contradictions might be 85 
explained by differences in Se status between geographic regions (11), distribution patterns between 86 
Se species and the reliability of the method of determination of Se (12). Whatever the case, those 87 
studies were limited by measurement only of total serum/plasma Se which does not allow distinction 88 
between different species of Se that may be transferred from mother to baby by different mechanisms.  89 
In investigating the relative concentrations of Se in mother and newborn it is important to take account 90 
of the different Se components in serum/plasma(13): two selenoproteins [selenoprotein P1 (SeP)(14) 91 
and the extracellular glutathione peroxidase GPx-3], Se incorporated non-specifically as 92 
selenomethionine (SeMet) in lieu of methionine in albumin (SeAlb) and other plasma proteins, and a 93 
small amount of non-protein-bound low molecular weight Se metabolites (SeMetab). SeP is the most 94 
abundant selenoprotein in plasma and is a good indicator of Se status in non-Se-replete humans (15). 95 
The activity of GPx-3 in human serum is a complementary marker of Se status. Importantly, GPx-3 96 
has been identified as a key enzyme in the defence against oxidative stress during decidualization 97 
(the post-ovulatory process of endometrial remodeling in preparation for implantation) by reducing 98 
H2O2 in the endometrium (16). 99 
We have been able to determine these species in serum from mother and baby pairs at time of birth 100 
owing to our previous development of a two-dimensional chromatographic method for simultaneous 101 
speciation of serum GPx-3, SeP, SeAlb and SeMetab (17). Although the accuracy of this method has 102 
been assessed by analyzing a commercial human serum (BCR-637), it has not previously been applied 103 
in a clinical setting. 104 
The aims of the current study were: (i)  to determine simultaneously Se, selenoproteins, SeAlb and 105 
SeMetab concentrations by this new method in both maternal and cord sera from uncomplicated 106 
pregnancies at the time of birth; (ii) to compare maternal and neonatal concentrations in order to 107 
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elucidate potential maternal-fetal transfer mechanisms; (iii) to assess whether SeP measured by 108 
2D/SE-AF-HPLC corresponded to that measured by ELISA and to assess the coherence between 109 
GPx-3 measured both as a concentration and an enzyme activity. Our study may also help to assess 110 
Se requirements in pregnancy, as recommended by the European Food Safety Authority (EFSA) 111 
Panel (18). 112 
METHODS 113 
A cross-sectional study was performed on 83 healthy mother-baby couples. Participants were 114 
recruited at random from pregnant women without any maternal or neonatal risk factors, who gave 115 
birth at term, at the Department of Obstetrics and Gynecology, Hospital de Riotinto, during the years 116 
2014-2015. Women with diseases, multiple gestation and perinatal complications such as obstructed 117 
labor, low Apgar score (below 5) or where there was suspicion of infant pathology, were excluded. 118 
A full history was taken from the enrolled mothers which included whether or not they took a 119 
multivitamin/mineral supplement [a standard formula approved by the Department of Health, 120 
containing 200 µg iodide (I-), 55µg Se, as sodium selenite, 10 mg zinc and 200 mg docosahexaenoic 121 
acid (DHA)] during pregnancy. Medical data from clinical examination of mothers and babies were 122 
also recorded at birth. 123 
This study was approved by the local Ethics Committee and written informed consent was obtained 124 
from all the participants. Since we also collected samples from cord blood, the parents provided 125 
separate, signed, informed consent for this specific purpose.  126 
Analytical procedures 127 
Blood samples were collected from mothers during the 24 hours before delivery. At birth, a sample 128 
of cord blood was obtained and its pH was measured. Serum was separated and frozen at -80ºC until 129 
further analysis.  130 
Se and selenoprotein concentrations were measured by a two-dimensional chromatographic method 131 
that used in-series size-exclusion, and high performance affinity liquid chromatography (2D/SE-AF-132 
HPLC), as previously described; this method overcomes common spectral interferences from chloride 133 
and bromide (17). Briefly, plasma and serum samples were filtered before injecting on to the 134 
chromatographic platform, which connected two in-series, stacked, 5 ml HiTrap®Desalting columns 135 
(for size exclusion separation), and a dual-affinity column arrangement comprising a 1 ml heparin-136 
sepharose column (HEP-HP, able to retain selectively SeP) and a 1 ml blue-sepharose column (BLU-137 
HP that retains both SeP and SeAlb) interconnected by a 6-port column-switching valve, in series 138 
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coupled to the ICP-MS system by means of a 30 cm PEEK tubing (0.6 mm i.d.) for Se detection. 139 
Ammonium acetate 0.05 M (at pH 7.5), Phase A, and 1.5 M Phase B, were successively used as 140 
mobile phase. Post-column isotope dilution analysis was performed by the introduction of 74Se via a 141 
T connector.  142 
Chromatographic performance was checked regularly by measuring control standards to ensure 143 
enough separation between species and method sensitivity after a considerable number of analyses. 144 
The proposed speciation method has been validated using a CRM of human serum (BCR-637) 145 
certified for total Se content (SeTotal= 81 ± 7 ng mL−1). The concentration of different Se species in 146 
BCR-637 obtained with this method has been compared with previous results for this CRM from 147 
Jitaru et al(19). The relative standard deviation (RSD, %) and the detection limits (LD, ng g−1 of Se) 148 
follow: GPx-3, RSD 21 and DL 0.2; SeP, RSD 12 and DL 0.7; SeAlb, RSD 9 and DL 0.9. 149 
SeP concentration was also analyzed by enzyme immunoassay (ELISA) (USCN Business Co., Ltd., 150 
Houston, TX), and GPx-3 activity by a commercial kit (Cayman Chemical, Ann Arbor, MI).  151 
Statistical analysis 152 
Sample size calculation: With 38 subjects per mother-baby group, and a standard deviation of 15 153 
µg/L of Se in mean serum Se concentration of 71 µg/L [obtained from a recent study of Spanish 154 
pregnant women (71.2± 14.9)](20), our study had 80% power to detect a difference of at least 10 µg/L 155 
in total serum Se between mother and baby groups at a two-sided, 5% significance level. We included 156 
83 healthy mother-baby couples. 157 
As our sample included women who took a mutivitamin/mineral supplement and women who did 158 
not, a comparison of means between these two groups was made to see wheteher this supplementation 159 
had a significant effect. Assuming a two- sided hypothesis, the conventional alpha and beta levels, 160 
and a proportion of 3:1 for the studied groups (the use of multivitamin/mineral supplements in our 161 
population barely reached a quarter of pregnant women), the sample size calculated was 19 women 162 
for the supplemented group and 57 pregnant women for the non- supplemented group. We included 163 
21 and 62 women, respectively. 164 
Data are presented as medians and standard deviations for continuous variables and as percentages 165 
for categorical variables. The contrast hypothesis for two samples was evaluated using Fisher´s exact 166 
test for categorized variables and Student´s t-test for continuous variables. Wilcoxon signed-rank test 167 
was used to compare matched samples. The correlation between variables was determined using the 168 
Spearman test, designing multiple linear regression models in those cases where it was desired to 169 
predict the variance adjusted for other variables, besides the main variable. The contrast hypothesis 170 
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for more than two samples was determined with an analysis of variance (ANOVA). All P-values were 171 
two-sided, and statistical significance was declared at P <0.05. All data were analyzed using SPSS 172 
20.0 (IBM SPSS Statistics).  173 
RESULTS  174 
Maternal and neonatal characteristics 175 
Table 1 shows maternal and neonatal characteristics. Since exclusively healthy pregnant women were 176 
recruited, the cesarean section rate was only 7.5% (compared to the usual cesarean section rate at our 177 
center of around 16%), and perinatal outcomes were good (there were no admissions to the Neonatal 178 
Intensive Care Unit).  179 
No correlations were found between maternal age, parity, body mass index or level of education and 180 
maternal Se concentration, nor were any correlations found between neonatal weight at birth or 181 
gestational age with maternal or neonatal serum Se concentrations. However, there was a negative 182 
correlation between hours of fasting prior to blood draw and total Se concentration in maternal serum 183 
(r = -0.30; p<0.05).  184 
Women who did not take multivitamin /mineral supplements (containing 55 µg Se) were significantly 185 
younger than women who did take them (29.42±5.35 vs 31.16±4.80 years, respectively; p<0.05). No 186 
significant differences in parity, body mass index or level of education were found between women 187 
who took multivitamin/mineral supplements and those who did not (data not shown). 188 
Se and selenoprotein concentrations by 2D/SE-AF-HPLC 189 
Total Se and selenoprotein concentrations in maternal and cord serum are summarized in Table 2. 190 
Total Se, GPx-3 and SeP concentrations were significantly higher in maternal than in cord serum, 191 
while SeAlb was significantly more concentrated in cord serum. There was no significant difference 192 
in the SeMetab concentration between maternal and cord serum. The chromatograms of maternal and 193 
umbilical cord sera are shown in Figure 1. 194 
The correlations between maternal and cord Se species were significant in all cases, reaching the 195 
highest value for GPx-3 and the lowest for SeP.  196 
The proportion of Se species in maternal and cord serum was different; while SeP accounted for 65% 197 
of total Se in maternal serum, it only represented 50% of total Se in cord serum. By contrast, SeAlb 198 
constituted 15% of total Se in maternal serum but 28% in cord serum. The percentages for GPx-3 and 199 
SeMetab were similar in maternal and cord sera: 14% for GPx-3 in both, and 7% and 8% for SeMetab 200 
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in maternal and cord sera, respectively (Figure 2a). When the Se species concentrations are 201 
represented graphically, the different pattern in maternal and cord serum is apparent (Figure 2b).  202 
There were no significant differences in the concentrations of Se species in maternal or cord serum 203 
between women who took multivitamins/minerals containing Se and those who did not (Table 3).  204 
Maternal total serum Se was strongly correlated with all the Se species in maternal serum, i.e. GPx-205 
3 (r=0.71; p<0.01), SeP (r=0.89; p<0.01), SeAlb (r=0.80; p<0.01) and SeMetab (r=0.42; p<0.01), 206 
and moderately correlated with the concentrations of the Se species in cord serum, i.e. total Se in cord 207 
serum (r=0.56; p<0.01), GPx-3 (r=0.47; p<0.01), SeP (r=0.43; p<0.01), SeAlb (r=0.45; p<0.01) and 208 
SeMetab (r=0.48; p<0.01). 209 
Total Se in cord serum was correlated with all the Se species studied in cord serum, i.e. GPx-3 210 
(r=0.78; p<0.01), SeP (r=0.89; p<0.01), SeAlb (r=0.80; p<0.01) and SeMetab (r=0.60; p<0.01), and 211 
moderately correlated with the concentration of the Se species in maternal serum, i.e. GPx-3 (r=0.64; 212 
p<0.01), SeP (r=0.32; p<0.01), SeAlb (r=0.61; p<0.01) and SeMetab (r=0.66; p<0.01). 213 
Negative correlations were found between umbilical-cord pH and maternal SeAlb (r= -0.33; p=0.01), 214 
cord total Se (r= -0.30; p=0.04) and cord SeAlb (r= -0.30; p=0.02). 215 
GPx-3 activity 216 
GPx-3 activity was significantly higher in maternal than in cord serum (112.87±68.91 and 217 
38.67±25.03 nmol/min/ml, respectively; p<0.01), and there was no correlation between the activities 218 
(r=0.12; p=0.48). There was a significant correlation between GPx-3 concentration and its activity in 219 
maternal serum (r=0.33; p=0.04), but this correlation was not apparent in cord serum (data not 220 
shown). Maternal GPx-3 activity also correlated significantly with total Se concentration in maternal 221 
serum (r=0.36; p=0.03) and with SeMetab concentration in cord serum (r=0.50; p<0.01), but not with 222 
other Se species in either maternal or cord serum (data not shown). GPx-3 activity in cord serum was 223 
significantly correlated with birth weight (r=0.39; p=0.02) and gestational age (r=0.43; p<0.01). This 224 
last correlation remained significant after adjusting by birth weight and height (R2=0.23; p=0.04). 225 
However, GPx-3 activity in cord serum did not correlate with total Se or Se species either in cord or 226 
maternal serum (data not shown). 227 
SeP measured by ELISA.  228 
SeP concentration determined by ELISA was significantly different in maternal and cord serum 229 
(38.27±12.34 µg/L and 1.93±0.98 µg/L respectively, p<0.01). No correlation was found between SeP 230 
in maternal and cord serum when measured by ELISA. There was no correlation between SeP 231 
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concentrations measured by HPLC and ELISA in either maternal or cord serum (data not shown). 232 
Although SeP concentration in maternal serum measured by HPLC and ELISA were not significantly 233 
different (42.49 ± 9.49 µg/L and 38.27 ± 12.34 µg/L respectively, p=0.10), there was a significant 234 
difference between these two methods of determination in cord serum (28.06 ± 7.69 µg/L by HPLC 235 
and 1.93 ± 0.98 µg/L by ELISA, p<0.01). Maternal SeP measured by ELISA correlated significantly 236 
with GPx3 concentration in cord serum (r=0.33; p=0.04). 237 
 238 
DISCUSSION 239 
This is the first study to analyse simultaneously total Se and Se species in maternal and cord serum 240 
at the time of birth using a new optimized HPLC method. Although some of these factors have 241 
previously been measured at delivery, the interrelationships between the different Se species in 242 
maternal and cord sera are largely unknown, as is the biological significance of such relationships. 243 
Our findings indicate that, at birth, total Se, GPx-3 and SeP concentrations are significantly higher in 244 
maternal than in cord serum while the opposite is the case for SeAlb. In general, simple diffusion 245 
cannot explain the maternal-neonatal transfer of Se and Se species around the time of birth. 246 
Oxidative stress is tightly related to perinatal morbidity and mortality, so the antioxidant 247 
selenoproteins may have a central role in protecting against adverse pregnancy outcomes(21). Thus 248 
total Se concentration and GPx-3 activity in cord serum were found to increase with advancing 249 
pregnancy(22) while oxidative stress during labor was associated with elevated fetal GPx-3 activity(23). 250 
A study in rats showed that a sufficient Se supply was required to ensure antioxidative protection to 251 
the fetus during the oxygen transformations that take place during delivery and early postnatal life(24). 252 
By contrast, in a UK population of slightly higher Se status than ours, maternal blood Se 253 
concentrations fell from 12 to 35 weeks of gestation (believed to be partly due to the expansion of 254 
plasma volume and partly due to receptor-mediated transfer of SeP from mother to fetus) and maternal 255 
GPx-3 activity did not change(25). 256 
Our study found lower Se concentrations than those reported in other studies of Spanish pregnant 257 
women(20,26). Using the most restrictive cut-off of 70 µg/L of total serum Se concentration required 258 
to optimize GPx-3 activity(27), 57 of 83 (69%) pregnant women in our study had insufficient serum 259 
Se to fulfill this requirement. However, based on alternative estimates of the range of serum Se 260 
concentration required for optimal GPx-3 activity, i.e., 89-114 µg/L(11), 90% of the women in our 261 
sample did not reach this optimal status.   262 
 9 
 
The dietary intake of Se is the major determinant factor of serum-Se concentration. Since we used 263 
data from medical records, information on dietary Se intake was not available. However, other factors 264 
have been reported to be associated with Se status such as sex (28,29) age, BMI(28), education(30), 265 
socioeconomic status(28,30) or physical activity(29), as well as location (31). In this regard, our patients 266 
came from a non-urban area in southern Spain where Se intake is traditionally low (31). Futhermore, 267 
most of them were overweight or obese, with a low level of education, had never worked or were 268 
unemployed. All these factors lead us to speculate that they were unlikely to eat the traditional diet 269 
with high consumption of vegetables and cereals(32). 270 
It might have been expected that pregnant women who took multivitamins/multiminerals containing 271 
sodium selenite would have had significantly higher concentrations of at least some Se species than 272 
those who did not, as sodium selenite can be used for the synthesis of selenoproteins such as GPx-3 273 
or SeP (though it will not increase SeAlb)(12). However, the absence of higher concentrations in the 274 
women on supplements is not altogether surprising as the Se dose was relatively low (55 µg/day), 275 
only 25% of the women took such supplements and, we have no data on their compliance. 276 
Furthermore, in vivo human studies showed that selenite is only moderately absorbed (between 56-277 
85%)(33). 278 
In recent years, Se status in maternal and cord blood at delivery has been determined in a number of 279 
studies, though with varied outcomes(34-36). Al-Saleh et al(34) examined the role of Se in reducing 280 
oxidative stress induced by cadmium and its impact on birth measures. They concluded that the extent 281 
of benefit afforded by Se is not governed only by its concentration but also by the different chemical 282 
forms of Se that interact with various proteins. Chen et al(35) attempted to clarify concentrations for 283 
cadmium, mercury, lead and Se in mothers and newborns and their placental transfer. Finding a high 284 
degree of maternal-fetal Se transfer, they concluded that there was free trans-placental passage of Se 285 
from mother to fetus. However, our results do not support that conclusion; the different pattern of 286 
transfer of SeP and SeAlb implies that different mechanisms are involved in the transfer of these 287 
different Se species from mother to fetus.  288 
It appears likely that receptor-mediated uptake exists in humans as previously found in pregnant 289 
mice(5). Burk and colleagues identified two mechanisms of Se transfer; from early to mid-gestation, 290 
plasma GPx-3 and SeP were transported via the uterine fluid, probably by pinocytosis, whereas in the 291 
latter half of gestation, placental transfer of maternal SeP occurred through the apoE receptor 2 292 
(apoER2)(5). In fact, the higher levels of SeAlb in cord serum compared to maternal serum suggest 293 
the existence of  a further maternal-fetal Se transfer mechanism(5,37). Studies in mice and rats suggest 294 
that this other pathway involves the transfer of Se as SeMet-containing proteins or SeMet itself (via 295 
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methionine transporters) to the fetus(5,37). This mechanism depends on the amount of SeMet in the 296 
diet of the mother, appears to be unregulated and is highly dependent on the mother´s Se status, thus 297 
it will be less effective under conditions of Se deficiency(5). The similar concentrations for SeMetab 298 
and their strong correlation in maternal and cord serum can be explained by a simple diffusion 299 
mechanism of trans-placental passage that does not occur for other Se species.  300 
GPx-3 activity was measured to see whether there was a correlation between GPx-3 concentrations 301 
and GPx-3 activity. As expected, the GPx-3 activity in maternal serum significantly correlated with 302 
maternal total Se and GPx-3 concentrations, but GPx-3 activity in cord serum only correlated with 303 
gestational age and birth weight. These results are in agreement with previous findings(38); it seems 304 
that GPx-3 activity in mothers at delivery is related to maternal Se status, while the GPx-3 activity in 305 
cord serum depends on gestational age(22). 306 
Finally, our study compared different methods of determining SeP: 2D/SE-AF-HPLC and ELISA. 307 
The growing replacement of traditional immunoassay techniques by liquid chromatography-tandem 308 
mass spectrometry (LC-MS/MS) has highlighted the advantages and limitations of each system as 309 
well as the disparity in results by the two methods(39). These two methods have been previously used 310 
and published(17,40) In our sample, the concentration of SeP in maternal serum measured by both 311 
methods gave a similar result, but this was not the case in cord serum where SeP concentration 312 
measured by ELISA was significantly lower than that measured by HPLC, and did not correlate with 313 
any other parameters. While these results may suggest that ELISA is not a reliable method of 314 
quantifying SeP in cord serum, other explanations are possible. SeP has three transcripts in humans 315 
although all variants begin with the same non-coding exon(41). The most abundant transcript in all 316 
tissues was SePa. However, all variants (SePa, b and c) showed tissue and developmental stage-317 
specific expression patterns in neonatal and adult tissues(41). These transcripts can synthetize different 318 
isoforms, varying in size and Se content(41) as previously proposed(42). Moreover, the silencing of 319 
each transcript results in a differential synthesis of SeP isoforms(41). In this respect, the antibodies 320 
used in ELISA kits could have a different affinity for the SeP isoforms present in serum. This could 321 
affect the binding of the antibody to the SeP protein in the ELISA and therefore give different results 322 
than techniques that do not use antibodies. A further determination of SeP levels by the use of kits 323 
from other suppliers could be considered but unfortunately we have no remaining cord blood samples. 324 
Alternatively, this discordance in the results of SeP concentration between 2D/SE-AF-HPLC and 325 
ELISA may suggest that in the newborn, the predominant SeP isoform is different from that found in 326 
the mothers, and perhaps, with different functions(41). It is also likely that full-length SeP has a higher 327 
Se content that the shorter isoforms(15). It has been suggested that while liver exports full-length SeP, 328 
other tissues secrete mostly shorter SeP isoforms, possibly for local use as a redox enzyme or as a 329 
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signaling molecule(15). Our finding supports the hypothesis that circulating truncated SeP isoforms 330 
might not reach the concentrations necessary for successful identification by ELISA(43). 331 
The current study has some limitations. Firstly, the absence of a food frequency questionnaire did not 332 
allow us to assess Se intake. Furthermore, the small proportion (25%) of women taking a supplement 333 
containing Se and the lack of compliance data may have prevented our finding significantly higher 334 
markers of status in that group. 335 
Our study has also certain strengths; our design made possible the collection of data and samples 336 
from healthy pregnant women and their newborns at the time of birth. The multiple biomarkers 337 
studied from the same patients and the availability of a robust and reliable method to determine 338 
simultaneously different Se species gave us an insight into the relationships between these Se species 339 
in mother and newborn. 340 
CONCLUSION 341 
There is a different pattern of Se species in maternal and cord serum at the time of birth which 342 
suggests the existence of different mechanisms of trans-placental passage of Se species from mother 343 
to fetus that are species-dependent.  344 
The lack of concordance in the SeP concentration measured by 2D/SE-AF-HPLC and ELISA 345 
suggests the possibility that the predominant SeP isoform in newborn may be different from that 346 
found in the mother; this possibility needs to be followed up in a later study. 347 
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Table 1: Main characteristics of participants. 487 
  Mean  SD 
Maternal characteristics     
Maternal age (Years)  29.7  5.7 
Maternal weight (kg)  81.48  14.35 
Body mass index (kg/m2)  31.84  8.32 
Parity 
‐ Primiparous 
‐ Multiparous 
 
49.4 % 
51.6 % 
 
Previous miscarriages 
‐ Yes 
‐ No 
 
22.2 % 
77.8% 
 
Use of supplements 
‐ None 
‐ Potassium iodide (KI) 
‐ Multivitamins 
 
 
11/83 (13.3%) 
51/83 (61.4%) 
21/83 (25.3%) 
 
Level of education 
‐ Low 
‐ Medium 
‐ High 
 
90% 
10% 
0% 
 
 
Working woman 
‐ No 
‐ Yes 
 
80% 
20% 
 
 
Consumption of iodized salt 
‐ No 
‐ Yes 
 
 
69.5 % 
30.5 % 
 
Weight gain during pregnancy (kg)  12.64  5.06 
Type of delivery: 
‐ Normal vaginal delivery 
‐ Vacuum/Forceps 
‐ Cesarean section 
 
75% 
17.5% 
7.5% 
 
 
Neonatal characteristics     
Gestational age  at birth (days)  275.2  8.4 
Birth weight (gr)  3392.84  408.91 
Birth height (cm)  50.32  1.56 
Head circumference (cm)  33.48  1.44 
Abdominal circumference (cm)   33.40  1.67 
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Table 2: Comparisons between concentrations of total Se, selenoproteins, SeAlb and SeMetab in maternal and cord sera measured by 3D/SE‐AF‐AEC‐HPLC.  
 
 
 
  Maternal serum  Cord serum  Correlation (r; p)  Difference in means (p) 
Total Se (µg/L)  68.95 ± 15.23  56.14 ± 14.61  0.56     <0.01  <0.01 
GPx‐3 concentration (µg/L)  11.24 ± 3.68  10.46 ± 3.48  0.74     <0.01  <0.01 
SeP concentration (µg/L)  42.49 ± 9.49  28.06 ± 7.69  0.25     <0.01  <0.01 
SeAlb (µg/L)  11.35 ± 3.59  14.14 ± 4.26  0.60     <0.01  <0.01 
SeMetab (µg/L)  4.32 ± 2.86  3.98 ± 2.38  0.60     <0.01  n.s 
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Table 3: Concentration of various Se species in maternal and cord serum in women who took 
multivitamin/mineral supplement containing Se during pregnancy and those who did not take 
such supplements.  
  No supplements (N=62)  Multivitamins (N=21)  p 
Maternal Total Se (µg/L)  67.40 ± 14.24  69.72 ± 15.32  0.54 
Maternal GPx‐3 (µg/L)  10.84 ± 3.38  11.57 ± 3.92  0.43 
Maternal SeP (µg/L)  41.44 ± 9.04  44.86 ± 10.25  0.16 
Maternal SeAlb (µg/L)  11.16 ± 3.38  11.09 ± 3.31  0.41 
Maternal SeMetab (µg/L)  4.35 ± 2.96  3.21 ± 1.45  0.18 
       
Cord Total Se (µg/L)  55.24 ± 13.32  55.12  ± 11.75  0.97 
Cord GPx‐3 (µg/L)  10.13 ± 3.24  10.84 ± 3.52  0.42 
Cord SeP (µg/L)  28.12 ± 7.70  27.12 ± 6.36  0.62 
Cord SeAlb (µg/L)  13.49 ± 3.46  14.51 ± 3.62    0.28 
Cord SeMetab (µg/L)  3.82 ± 2.16  3.67 ± 2.26  0.83 
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